current page

Corporate Profile

TERUMO, founded in 1921, with Corporate Headquarters in Tokyo, Japan, is a leading manufacturer of medical devices with over 20,000 Associates across the world. Terumo India Pvt. Ltd., was established in 2013 with headquarters based in Gurgaon, NCR Delhi. In India, Terumo has an expanding field force & distribution network including several acclaimed academic programmes. Contributing to Society through Healthcare’ is both Terumo’s starting point and unchanging corporate mission. To fulfil this mission, we strive to respond to India’s health system skill requirements by working continuously in collaboration with our customers and our academic partners to contribute to skill enhancement and patient out-reach through our various CSR initiatives. This also inspires us to relentlessly stay committed to our work – to bring new value to the ever-changing medical settings, and to patients who await vital care. Terumo contributes to society through three business areas – Cardiac and Vascular business, Blood Management business, General hospital business. Each of our Associates are charged with producing innovation not only in product development and production, but also in each of our work processes as well. It is with this ‘Associate Spirit’ that we will continue our pursuit of new value to realize our vision. Terumo will further strive to be of value to patients, medical professionals, and society at large. We are proud that we touch 10000 lives everyday.

Company Name Terumo India Private Limited
Head Office 1601 & 1602, Unitech Cyber Park,Tower B, 16th Floor, Sector- 39,
Gurgaon 122001, India
Customer Contact no. + 91. 124.471-8700
Email ID customercareindia@terumo.co.jp Fax: +91. 124. 4718718 CIN: U33110HR2013FTC049841
Date of Establishment 15-Jul-13
Parent Company Name Terumo Corporation
Head Office 2-44-1 Hatagaya, Shibuya-ku, Tokyo, 151-0072 Japan
Tel. +81-3-3374-8111
Date of Establishment September 17, 1921
Corporate Stock First section of the Tokyo Stock Exchange
(Code: 4543)
Capital Stock 38.7 billion yen
Net Sales 599.5 billion yen (for FYE Mar. 2019)

The Latest Financial Results

Representative Management Takayoshi Mimura, Chairman of the Board
Shinjiro Sato, President and CEO
Number of Employees 20,697 (Consolidated)
Main Business Manufacture and sales of medical products and equipment, including pharmaceuticals, nutritional food supplement, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital thermometers.
Global Network

Global Network


Return to page top